Pneumococcal Conjugate Vaccine formulation 1: Clinical Trials

1 trial of Pneumococcal Conjugate Vaccine formulation 1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Pneumococcal Conjugate Vaccine formulation 1: new trials by email Literature Review of Pneumococcal Conjugate Vaccine formulation 1 trials Research Report on Pneumococcal Conjugate Vaccine formulation 1

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
Pneumococcal Conjugate Vaccine formulation 1, Pneumococcal Conjugate Vaccine formulation 2, Pneumococcal Conjugate Vaccine formulation 3 - Pneumococcal Immunisation, Diphtheria Immunisation
Phase 2CompletedSanofi Pasteur, a Sanofi Company8522020-05-222025-09-08

Sponsors

Sanofi Pasteur, a Sanofi Company (1)

Countries

Canada (1)  ·  Honduras (1)  ·  Puerto Rico (1)  ·  United States (1)